Electrophoresis Reagents Market Size, Share, Growth Report 2030

Electrophoresis Reagents Market

Electrophoresis Reagents Market By Product (Buffers, Gels, Dyes, Other Reagents), By Technique (Capillary Electrophoresis, Gel Electrophoresis), By Application (DNA and RNA Analysis, Protein Analysis), By End-User (Pharmaceutical and Biotechnology Companies, Hospitals and Diagnostic Laboratories, Academic and Research Institutions, Others): Global Industry Perspective, Comprehensive Analysis, And Forecast, 2020 – 2028

Category: Healthcare Report Format : PDF Pages: 166 Report Code: ZMR-998 Published Date: Oct-2021 Status : Published

The global electrophoresis reagents market accounted for USD 1,016.2 Million in 2020 and is estimated to reach USD 1,496.3 Million by 2028, growing at a CAGR of 5.2% from 2021 to 2028.

Electrophoresis Reagents Market

Global Electrophoresis Reagents Market Size And Industry Analysis

The global electrophoresis reagents market accounted for USD 1,016.2 Million in 2020 and is estimated to reach USD 1,496.3 Million by 2028, growing at a CAGR of 5.2% from 2021 to 2028.

Electrophoresis reagents are the gel and buffers are used for the electrophoretic separation of biological molecules. Electrophoresis is a technique in which macromolecules such as DNA, RNA, and Proteins are detected and separated based on their size and charge. This technique is extensively used in research and development activities in the fields of proteomics, genomics, clinical research, academic institutes and diagnostic laboratories.

The market is witnessing rise in clinical diagnosis owing to the rising geriatric population. The increasing prevalence of chronic diseases, growing investments in R&D in the genomics and proteomics industry are contributing to the market.

The emerging trend of use of gel electrophoresis along with RTPCR test for detection of SARS-CoV-2 escalating the market demand for electrophoretic reagents.

Global Electrophoresis Reagents Market SizeRequest Free Sample

COVID-19 Impact Analysis

All industries were significantly impacted due to the Covid-19 outbreak. The sudden spread of covid had tested the healthcare potential of all the countries across the globe. The market disruptions in supply chain and manufacturing processes due to stringent lockdown regulations. But the overall covid-19 scenario had positively impacted the global electrophoretic reagents market. The extensive spread of covid-19 accelerated the research and development activities across the globe. This growth in research provided an opportunity for the electrophoresis reagent market. The emerging governments across the globe are focusing on developments of new drugs and treatment methods owing to this proteomics and genomics projects are increasing providing high potential demand for electrophoretic reagents. All these growth opportunities are estimated to recover the market loss incurred during the lockdown.

The gel electrophoresis technique along with the RTPCR test was extensively used for the detection of SARS-CoV-2. The government strategies to conduct testing on large scale to stop the spread of covid-19 infections had bolstered the demand for electrophoresis reagents. Thus, overall Covid-19 has a positive impact on the electrophoresis reagent market.

Growth Factors

The growing prevalence of chronic diseases, genetic disorders, infectious diseases, and cancer are contributing to the high market demand for electrophoretic reagents. The rise in clinical diagnosis owing to the rising prevalence of infectious diseases and covid-19 outbreak is leading to a surge in electrophoretic reagents market demand. The market is majorly driven by the rising aged population, extending research and development activities in proteomics, genomics and research industry, technological advancements in R&D, and healthcare reforms by the government.

The increasing use of electrophoresis reagents in preclinical research and drug discovery is fueling the market demand. The governments of emerging economies are increasing their investments in R&D to strengthen their healthcare industry. The factors like rising healthcare expenditure and increase in per capita income are estimated to drive the market growth in the forecast period.

Report Scope: 

 

Technique Segment Analysis Preview

The gel electrophoresis segment held a share of around 61.77% in 2020. This is attributable to the rise in clinical diagnosis and escalating research activities by biotechnology and pharmaceutical companies. The gel electrophoresis technique is widely being adopted due to lower operating and instrument costs. The factors contributing to the growth of gel electrophoresis technique is easy to perform and provides accurate results as compared to other techniques. The increasing applications of electrophoresis reagents in the healthcare industry, preclinical trials, and research centers are estimated to drive the market growth of the gel electrophoresis segment in the forecast period.

Fig. Technique Segment Pie Chart as given below

Global Electrophoresis Reagents Market ShareRequest Free Sample

End Use Industry Segment Analysis Preview

The pharmaceutical and biotechnology companies’ segment will grow at a CAGR of over 36.59% from 2021 to 2028. This is attributable to the increasing demand for vaccines and curative drugs. The pharmaceutical and biotechnology companies are investing in the research and development of products owing to this the research activities are on the surge. This is the surge in research is driving the market demand for electrophoresis reagents. Followed by this, academic and research institutes are the second major share-holder of the market. This is attributable to wide applications of electrophoresis reagents in academic and research centers. The emerging economies are investing and increasing expenditure in research and new drug development, this is estimated to drive the market demand in the forecast period.

Regional Analysis Preview

The North American region held a share of 381.7 % in 2020. North America had the largest market share in 2020. This is attributable to growing drug discovery projects and technological advancements in clinical diagnosis technologies. The increasing prevalence of chronic diseases and cancer accelerated research activities for cure and disease prevention. These research activities involve biomolecules like proteins, DNA and RNA. To separate these biomolecules electrophoresis technique is implemented. This extensive use of electrophoresis agents is driving the market demand in this region. The developed countries in this region are having stringent regulations by drug safety authorities which are contributing to growth in demand for the electrophoresis reagents in this region.

The Asia Pacific region is estimated to grow at a CAGR of 7% over the forecast period. This surge is due to the presence of a large number of academic and research institutes in developing countries like China and India The increasing applications of electrophoresis reagents in research and clinical diagnosis are providing growth opportunities for manufacturers in the Asia-Pacific region. According to WHO, chronic pulmonary disease, cancer, diabetes, and cardiovascular diseases are the major prevailing diseases in the APAC region. This growth is creating demand for clinic diagnosis and is growing demand for electrophoresis reagents. The government initiatives towards improving healthcare infrastructure and increasing investment activities in research and development are estimated to drive the market demand in the forecast period. APAC region is estimated to be a fast-growing market segment in the forecast period.

Global Electrophoresis Reagents Market Regional AnalysisRequest Free Sample

Key Market Players & Competitive Landscape

Some of the key players electrophoresis reagents in the market are BioAtlas, Lonza bioscience, Bio-Rad Laboratories Inc., Agilent Technologies, Harvard Bioscience Inc., QIAxcel Advanced System, Merck Millipore, Thermo Fisher Scientific, Sigma-Aldrich Corporation, Takara Bio and Sebia Group.

These key market players are implementing various strategies to strengthen their footprints in the global and regional markets. These strategies include mergers and acquisitions, partnerships, collaborations for reagent development, and joint ventures.

Ex. 1) In September 2021, Sciex company launched a new capillary electrophoresis system named BioPhase8800 for the biological characterization during biopharmaceutical therapies.

2) In September 2020, Hitachi High-Tech Corporation had a collaboration with Promega Corporation for the development of Hitachi DS3000. It is a compact capillary electrophoresis sequencer.

The global electrophoresis reagents market is segmented as follows:

By Product

  • Gels (Polyacrylamide, Starch, & Agarose)
  • Buffer (TAE Buffer, TBE Buffer, And Other Buffers)
  • Dyes (ETBR, SYBR, Bromophenol Blue And Others)
  • Other Reagents

By Technique

  • Capillary Electrophoresis
  • Gel Electrophoresis.

By Application

  • DNA And RNA Analysis
  • Protein Analysis.

By End-User

  • Pharmaceutical And Biotechnology Companies
  • Hospitals And Diagnostic Laboratories
  • Academic And Research Institutions
  • Others

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

Methodology

FrequentlyAsked Questions

The global electrophoresis reagents market was valued at USD 1,016.2 Million in 2020.

The global electrophoresis reagents market is expected to reach USD 1,496.3 Million by 2028, growing at a CAGR of 5.2% between 2021 to 2028.

Some of the key factors driving the global electrophoresis reagents market growth are the rise in clinical diagnosis owing to the rising geriatric population and increasing prevalence of chronic diseases, growing investments in R&D in the genomics and proteomics industry.

North America region held a substantial share of the electrophoresis reagents market in 2020. This is attributable to growing drug discovery projects and technological advancements in clinical diagnosis technologies. This extensive use of electrophoresis agents is driving the market demand in this region.

Some of the major companies operating in the electrophoresis reagents market are BioAtlas, Lonza bioscience, Bio-Rad Laboratories Inc., Agilent Technologies, Harvard Bioscience Inc., QIAxcel Advanced System, Merck Millipore, Thermo Fisher Scientific, Sigma-Aldrich Corporation, Takara Bio and Sebia Group.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed